Twist Bioscience Corp (TWST)
42.20
+0.84
(+2.03%)
USD |
NASDAQ |
May 24, 10:09
Twist Bioscience Enterprise Value: 2.115B for May 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 2.115B |
| May 22, 2024 | 2.216B |
| May 21, 2024 | 2.271B |
| May 20, 2024 | 2.319B |
| May 17, 2024 | 2.444B |
| May 16, 2024 | 2.414B |
| May 15, 2024 | 2.522B |
| May 14, 2024 | 2.509B |
| May 13, 2024 | 2.468B |
| May 10, 2024 | 2.174B |
| May 09, 2024 | 2.222B |
| May 08, 2024 | 2.117B |
| May 07, 2024 | 2.218B |
| May 06, 2024 | 2.308B |
| May 03, 2024 | 2.106B |
| May 02, 2024 | 1.570B |
| May 01, 2024 | 1.568B |
| April 30, 2024 | 1.525B |
| April 29, 2024 | 1.572B |
| April 26, 2024 | 1.541B |
| April 25, 2024 | 1.514B |
| April 24, 2024 | 1.495B |
| April 23, 2024 | 1.539B |
| April 22, 2024 | 1.420B |
| April 19, 2024 | 1.332B |
| Date | Value |
|---|---|
| April 18, 2024 | 1.356B |
| April 17, 2024 | 1.368B |
| April 16, 2024 | 1.371B |
| April 15, 2024 | 1.407B |
| April 12, 2024 | 1.491B |
| April 11, 2024 | 1.607B |
| April 10, 2024 | 1.560B |
| April 09, 2024 | 1.668B |
| April 08, 2024 | 1.624B |
| April 05, 2024 | 1.603B |
| April 04, 2024 | 1.567B |
| April 03, 2024 | 1.646B |
| April 02, 2024 | 1.621B |
| April 01, 2024 | 1.708B |
| March 31, 2024 | 1.702B |
| March 28, 2024 | 1.673B |
| March 27, 2024 | 1.682B |
| March 26, 2024 | 1.640B |
| March 25, 2024 | 1.668B |
| March 22, 2024 | 1.689B |
| March 21, 2024 | 1.772B |
| March 20, 2024 | 1.736B |
| March 19, 2024 | 1.644B |
| March 18, 2024 | 1.645B |
| March 15, 2024 | 1.634B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
268.48M
Minimum
May 02 2023
9.527B
Maximum
Jan 20 2021
2.300B
Average
1.534B
Median
Enterprise Value Benchmarks
| Tandem Diabetes Care Inc | 3.088B |
| Perspective Therapeutics Inc | 761.23M |
| Xtant Medical Holdings Inc | 122.50M |
| Asensus Surgical Inc | 58.57M |
| Catheter Precision Inc | 2.633M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -45.49M |
| Revenue (Quarterly) | 75.30M |
| Total Expenses (Quarterly) | 124.19M |
| EPS Diluted (Quarterly) | -0.79 |
| Gross Profit Margin (Quarterly) | 41.01% |
| Profit Margin (Quarterly) | -60.41% |
| Earnings Yield | -7.96% |
| Normalized Earnings Yield | -7.421 |